Given that SP and PAMP-12 are implicated in urticaria, atopic dermatitis, and allergic contact dermatitis, it should be possible to utilize C9 or small molecules based on this compound for topical application to treat these conditions. The gene discussed is ADM; the disease is allergic contact dermatitis.